Symbol Surfing makes it fast & easy to find your next great idea. Just select a channel to get started.

Regeneron Pharmaceuticals (NASDAQ: REGN)

REGN 651.88
1.30 (0.2%)

Open: 649.17 High: 653.00 Low: 643.29


External Links

52WL $446.38

The 52 Week Low is $446.38 set on Wed, Mar 3, 2021. The current price, $651.88, is 46% above the 52 Week Low.

52WH $686.28

The 52 Week High is $686.28 set on Wed, Sep 1, 2021.

ATH $686.28

The All-Time High is $686.28 set on Wed, Sep 1, 2021.

52 Week Range

Mar 3, 2021
Sep 1, 2021

REGN Earnings

Q1 Earnings for Jan, Feb & Mar

Thu, May 6, 2021

Since Q1 Earnings Report

REGN 35.1%

Q2 Earnings for Apr, May & Jun

Thu, Aug 5, 2021

Since Q2 Earnings Report

REGN 12.2%

REGN Profile

Regeneron Pharmaceuticals trades on the NASDAQ. REGN's market cap is 69.7 Billion.

Regeneron Pharmaceuticals discovers, develops, and commercializes products that fight eye disease, cardiovascular disease, cancer, and inflammation. The company has several marketed products including: Eylea, approved for wet age-related macular degeneration and other eye diseases; Praluent for LDL cholesterol lowering; Dupixent in atopic dermatitis, asthma, and nasal polyposis; Libtayo in cutaneous squamous cell carcinoma; and Kevzara in rheumatoid arthritis. Regeneron is also developing monoclonal antibodies with Sanofi in immunology and cancer, and bispecific antibodies and antibody cocktails with other collaborators and independently.


Related Channels

YouTube Symbol Surfing

Watch these videos to learn how Symbol Surfing can increase your trading and investing knowledge and results.